Mitochondria, an exciting new target for the treatment of anxiety disorders
from Max Planck Society via Medical Xpress
One third of patients with anxiety disorders do not respond to currently available anxiolytic treatments. In their latest study, scientists at the Max Planck Institute of Psychiatry in Munich have shown for the first time that manipulation of mitochondria exerts anxiolytic effects. This improved understanding of how mitochondrial changes affect anxiety may provide the key to novel treatments.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063